Proposed Biotech Policy Board Debated

Washington - A proposal for a permanent body to stimulate biotechnology research and its commercial applications has triggered political tug-of-War over the right to shape federal policy. The Senate is expected to act a early as this spring on a bill (S. 1966) to set up a National Biotechnology Policy Board with 20 members drawn from government agencies, industry and academia. The board would be a permanent body within the executive branch and would produce a report every two years, beginning

Written byJeffrey Mervis
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The Senate is expected to act a early as this spring on a bill (S. 1966) to set up a National Biotechnology Policy Board with 20 members drawn from government agencies, industry and academia. The board would be a permanent body within the executive branch and would produce a report every two years, beginning January 1990. The bill carries a five-year budget authorization, starting at $2 million and rising to $3 million by 1992, for a staff to carry out its duties. Washington - The National Science Foundation's plan to fund $30 million in university-based science and technology centers is dead for this year, according to NSF sources. But the program will get a boost in the 1989 budget that President Reagan will submit next Week. A tight 1988 budget has forced NSF officials to delay plans to begin the centers program this year. At press time NSF was still ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies